| CTMX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CTMX shares outstanding history going back to 10/8/2015:
Also see: CTMX Market Cap History CTMX YTD Return |
CTMX Shares Outstanding History — CytomX Therapeutics Share Count Over Time
As of 4/30/2026 CytomX Therapeutics has 217.70 million CTMX shares outstanding. Investors often track the CTMX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CTMX share count trends over time, with 45 historical shares outstanding datapoints presented, dating back to 10/8/2015.
| CTMX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CTMX Historical Shares Outstanding: +18.91% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CTMX Stock Price Chart |
| About CytomX Therapeutics Inc |
| CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. It is advancing potential first-in-class and best-in-class antibody-based therapeutics created using its PROBODY therapeutic technology platform. Its pipeline comprises therapeutic candidates across multiple treatment modalities including antibody-drug conjugates (ADCs), T-cell engagers, and immune modulators such as cytokines. Its clinical-stage pipeline includes CX-904, CX-2051 and CX-801. We show 45 historical shares outstanding datapoints in our coverage of CTMX's shares outstanding history. Understanding the changing numbers of CTMX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CTMX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CTMX by allowing them to research CTMX shares outstanding history as well as any other stock in our coverage universe. |
| CTMX Current Stock Quote |
Quotes delayed 20 minutes  Free CTMX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CTMX Share Performance |
| Shares Outstanding Peers |
| CytomX Therapeutics (CTMX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CTNM Shares Outstanding History CTRV Shares Outstanding History CTSO Shares Outstanding History CTXR Shares Outstanding History CUE Shares Outstanding History CUR Shares Outstanding History CUTR Shares Outstanding History CVKD Shares Outstanding History CVRX Shares Outstanding History CVS Shares Outstanding History More Healthcare companies » |
CTMX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
